Combination docetaxel plus vitamin D3 as an immune therapy in animals bearing squamous cell carcinomas

Otolaryngology - Head and Neck Surgery

Volumn 133, Issue 4, 2005, Pages 611-618

  Young, M Rita I ^a,b   Lathers, Deanne M R ^a,b  

^a RALPH H JOHNSON VA MEDICAL CENTER   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; COLECALCIFEROL; DOCETAXEL;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER MODEL; CONTROLLED STUDY; DENDRITIC CELL; DRUG EFFICACY; HEAD AND NECK CANCER; IMMUNE RESPONSE; IMMUNOTHERAPY; LYMPH NODE; MOUSE; NONHUMAN; SPLEEN; SQUAMOUS CELL CARCINOMA; T LYMPHOCYTE; TUMOR;

ANIMALS; ANTIGENS, CD; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, SQUAMOUS CELL; CELL COUNT; CHOLECALCIFEROL; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; DRUG THERAPY, COMBINATION; INTERFERON TYPE II; LYMPH NODES; MICE; SPLEEN; STEM CELLS; T-LYMPHOCYTES; TAXOIDS; VITAMINS;

EID: 26444540659     PISSN: 01945998     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.otohns.2005.05.658     Document Type: Article

References (21)

1. F. Benvenuti, C. Lagaudriere-Gesbert, I. Grandjean Dendritic cell maturation controls adhesion, synapse formation, and the duration of the interactions with naive T lymphocytes J Immunol 172 2004 292 301
2. + T cells J Immunol 163 1999 3597 3604
3. F. De Paola, R. Ridolfi, A. Riccobon Restored T-cell activation mechanisms in human tumour-infiltrating lymphocytes from melanomas and colorectal carcinomas after exposure to interleukin-2 Br J Cancer 88 2003 320 326
4. M.R. Young, D.M. Lathers Myeloid progenitor cells mediate immune suppression in patients with head and neck cancers Int J Immunopharmacol 21 1999 241 252
5. T.Y. Shibuya, W.Z. Wei, M. Zormeier Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma Arch Otolaryngol Head Neck Surg 126 2000 473 479
6. J.H. Heimdal, H.J. Aarstad, B. Klementsen Peripheral blood mononuclear cell (PBMC) responsiveness in patients with head and neck cancer in relation to tumour stage and prognosis Acta Otolaryngol 119 1999 281 284
7. S.W. Chandler, C.H. Rassekh, S.M. Rodman Immunohistochemical localization of interleukin-10 in human oral and pharyngeal carcinomas Laryngoscope 112 2002 808 815
8. + suppressor lymphocytes in the circulation of patients immunized against melanoma antigens J Immunother 26 2003 85 93
9. + cells in cancers that secrete granulocyte-macrophage colony-stimulating factor Clin Cancer Res 1 1995 95 103
10. + immune suppressive cells in the peripheral blood of patients with head and neck cancer Ann Otol Rhinol Laryngol 109 2000 749 754
11. M.R.I. Young, M.A. Wright, J.P. Matthews Suppression of T cell proliferation by tumor-induced granulocyte-macrophage progenitor cells producing transforming growth factor-β and nitric oxide J Immunol 156 1996 1916 1922
12. + cells to differentiate into antigen presenting dendritic cells Clin Cancer Res 125 2001 205 212
13. 3 in human colon cancer cells Cancer Res 63 2003 7799 7806
14. 3 analogues a novel class of potent inhibitors of proliferation and inducers of differentiation of human breast cancer cell lines Cancer Res 55 1995 2822 2830
15. 3 in induction of myeloid differentiation of human leukemic cell lines J Leukoc Biol 51 1992 237 243
16. + cells Int J Cancer 73 1997 663 669
17. 3 Cancer Immunol Immunother 53 2004 422 430
18. N. Tsavaris, C. Kosmas, M. Vadiaka Immune changes in patients with advanced breast cancer undergoing chemotherapy with taxanes Br J Cancer 87 2002 21 27
19. K.K. Fu, P.A. Rayner, K.N. Lam Modification of the effects of continuous low dose rate irradiation by concurrent chemotherapy infusion Int J Radiat Oncol Biol Phys 10 1984 1473 1478
20. H. Inohara, T. Inoue, S. Akahani Concurrent chemoradiotherapy with cisplatin and docetaxel for advanced head and neck cancer. A phase I study Anticancer Res 24 2004 4135 4140
21. 3 diminishes tumor-induced myelopoiesis and associated immune suppression, and reduces tumor metastasis and recurrence Cancer Immunol Immunother 41 1995 37 45